Evanthia Galanis, MD
Alliance Foundation Trials, LLC. · Alliance Foundation Trials · Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Evanthia Galanis, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07149363 · Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung CancerAlliance Foundation Trials, LLC. · recruiting · Small Cell Lung Cancer (SCLC) · principal investigator
- Ph2NCT05798663 · Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLCAlliance Foundation Trials, LLC. · active not recruiting · NSCLC · principal investigator
- Ph2NCT04335682 · Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamideAlliance Foundation Trials, LLC. · completed · Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer · principal investigator
- Ph2NCT04062708 · CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung CancerAlliance Foundation Trials, LLC. · active not recruiting · Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer · principal investigator
- Ph2NCT04009109 · Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MMAlliance Foundation Trials, LLC. · active not recruiting · Myeloma, Multiple · principal investigator
- Ph1NCT03702725 · Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple MyelomaAlliance Foundation Trials, LLC. · completed · Refractory Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma · principal investigator
- Ph2NCT03478514 · Phase II Palbociclib +Ibrutinib in Mantle Cell LymphomaAlliance Foundation Trials, LLC. · active not recruiting · Mantle Cell Lymphoma, B Cell Lymphoma · principal investigator
- Ph3NCT03009981 · A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerAlliance Foundation Trials, LLC. · completed · Prostate Cancer · principal investigator
- Ph3NCT02513394 · PALbociclib CoLlaborative Adjuvant StudyAlliance Foundation Trials, LLC. · active not recruiting · Breast Cancer · principal investigator
- Ph1/Ph2NCT02068794 · MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube CancerMayo Clinic · active not recruiting · Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma · principal investigator
- Ph2NCT00892177 · Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma MultiformeAlliance for Clinical Trials in Oncology · completed · Glioblastoma Multiforme · study chair
- Ph2NCT00621686 · Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeAlliance for Clinical Trials in Oncology · completed · Brain and Central Nervous System Tumors · study chair
- Ph1NCT00408590 · Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal CancerMayo Clinic · completed · Ovarian Cancer, Primary Peritoneal Cavity Cancer · study chair
- Ph2NCT00098553 · Everolimus in Treating Patients With Stage IV MelanomaAlliance for Clinical Trials in Oncology · completed · Melanoma (Skin) · unknown
- Ph2NCT00005976 · Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent GliomaNational Cancer Institute (NCI) · completed · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Mayo Clinic Ovarian Cancer SPOREP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Jamie N Bakkum-Gamez, SCOTT H KAUFMANN · fiscal years 2015 to 2026Named on NCT02068794, NCT00408590
- Optimizing Delivery of Oncolytic Measles Virus Strains with Cell CarriersR01CA200507 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis · fiscal years 2017 to 2020Named on NCT02068794
- R01CA136547RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT02068794
- Pathology Research Shared ResourceP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2015 to 2026Named on NCT00408590
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.